Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-Blind Study of SB206 in Japanese Patients with Molluscum Contagiosum
jRCT2031240677Completed
- Sponsor
- Sato Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in molluscum contagiosum (MC) comparing SB206 arm with Vehicle arm (2 arms). Primary endpoint: Complete clearance of all treatable molluscum contagiosum lesions at Week 12. Started Mar 2025; status: completed.
02
Drugs
berdazimer
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on jRCT2031240677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240677.